Clinical utility of measuring Epstein–Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

Nicolaus Kröger, Carlos Solano, Christine Wolschke et al. · New England Journal of Medicine · 2016 · 558 citations · Full text

Life Sciences, Hematology, Immunology +13

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell–depleted SCT

Joost W. J. van Esser, Bronno van der Holt, Ellen Meijer et al. · Blood · 2001 · 371 citations · Full text

Medicine, Hematology, Immunology +14

Response to Rituximab-Based Therapy and Risk Factor Analysis in Epstein Barr Virus–Related Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplant in Children and Adults: A Study From the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation

Jan Styczyński, Lidia Gil, Gloria Tridello et al. · Clinical Infectious Diseases · 2013 · 249 citations · Full text

Medicine, Hematology, Infectious Diseases +13

Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data

Richard Simon, J. Subramanian, Ming Li et al. · Briefings in Bioinformatics · 2011 · 228 citations · Full text

Public Health, Biostatistics, Biotechnology +15

Association between anti-thymocyte globulin exposure and survival outcomes in adult unrelated haemopoietic cell transplantation: a retrospective, pharmacodynamic cohort analysis

Rick Admiraal, Stefan Nierkens, Moniek A. de Witte et al. · The Lancet Haematology · 2017 · 213 citations · Full text

Medicine, Hematology, Immunology +17